Total Payments
$1,844
2022 Payments
$53.72
Companies
23
Transactions
81
Medicare Patients
641
Medicare Billing
$52,483
Payment Breakdown by Category
Food & Beverage$1,844 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,844 | 81 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $294.84 | 10 | $0 (2021) |
| Mayne Pharma Inc. | $227.62 | 9 | $0 (2018) |
| Celgene Corporation | $217.64 | 15 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $179.76 | 7 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $145.05 | 4 | $0 (2019) |
| Allergan Inc. | $118.12 | 1 | $0 (2017) |
| LEO Pharma Inc. | $110.07 | 6 | $0 (2019) |
| Galderma Laboratories, L.P. | $88.35 | 5 | $0 (2018) |
| PFIZER INC. | $69.77 | 4 | $0 (2022) |
| GENZYME CORPORATION | $61.10 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $53.72 | 3 | Amgen Inc. ($20.89) |
| 2021 | $177.30 | 4 | AbbVie Inc. ($157.83) |
| 2020 | $14.73 | 1 | Amgen Inc. ($14.73) |
| 2019 | $154.12 | 8 | Novartis Pharmaceuticals Corporation ($44.67) |
| 2018 | $592.29 | 33 | Celgene Corporation ($186.89) |
| 2017 | $852.14 | 32 | Mayne Pharma Inc. ($128.29) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/29/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/21/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Inflammation | ||||||
| 03/17/2022 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Inflammation & Immunology | ||||||
| 09/29/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $115.29 | General |
| Category: IMMUNOLOGY | ||||||
| 08/31/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: IMMUNOLOGY | ||||||
| 07/27/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/22/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: IMMUNOLOGY | ||||||
| 01/23/2020 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Inflammation | ||||||
| 11/18/2019 | Ortho Dermatologics, a division of Bausch Health US, LLC | DUOBRII (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: DERMATOLOGY | ||||||
| 10/02/2019 | Mission Pharmacal Company | Ovace (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Antibacterial (topical) | ||||||
| 09/05/2019 | AbbVie, Inc. | Skyrizi (Biological) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Immunology | ||||||
| 04/23/2019 | DERMIRA, INC. | — | Food and Beverage | In-kind items and services | $20.73 | General |
| 03/15/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: DERMATOLOGY | ||||||
| 03/13/2019 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: DERMATOLOGY | ||||||
| 02/19/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: DERMATOLOGY | ||||||
| 01/17/2019 | GENZYME CORPORATION | DUPIXENT (Drug), DERMATITIS - DISEASE | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Immunology | ||||||
| 10/16/2018 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $17.09 | General |
| 10/16/2018 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $2.95 | General |
| 10/09/2018 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $3.38 | General |
| 09/27/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Immunology | ||||||
| 08/23/2018 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $5.33 | General |
| 08/15/2018 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $38.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/07/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Immunology | ||||||
| 07/24/2018 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 8 | 223 | 345 | $50,501 | $14,226 |
| 2021 | 8 | 221 | 495 | $72,542 | $22,373 |
| 2020 | 6 | 197 | 360 | $55,170 | $15,884 |
Total Patients
641
Total Services
1,200
Medicare Billing
$52,483
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 63 | $14,490 | $3,872 | 26.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 26 | 29 | $8,424 | $2,690 | 31.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $6,840 | $1,999 | 29.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 37 | 41 | $5,945 | $1,578 | 26.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 30 | 32 | $5,388 | $1,321 | 24.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 11 | 11 | $4,654 | $1,303 | 28.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 14 | 14 | $2,590 | $772.98 | 29.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 23 | 131 | $2,171 | $690.07 | 31.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 106 | $23,618 | $7,551 | 32.0% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 28 | 40 | $11,507 | $3,769 | 32.8% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 14 | 21 | $8,819 | $3,007 | 34.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 39 | 60 | $8,580 | $2,744 | 32.0% |
| 17000 | Destruction of skin growth | Office | 2021 | 31 | 40 | $6,839 | $1,731 | 25.3% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 12 | 13 | $4,309 | $1,412 | 32.8% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 25 | 195 | $3,337 | $1,115 | 33.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $5,533 | $1,043 | 18.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 60 | 86 | $15,910 | $4,662 | 29.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 51 | 58 | $15,660 | $4,224 | 27.0% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 31 | 36 | $10,080 | $3,262 | 32.4% |
| 17004 | Destruction of 15 or more skin growths | Office | 2020 | 13 | 16 | $6,240 | $1,836 | 29.4% |
| 17000 | Destruction of skin growth | Office | 2020 | 23 | 25 | $4,500 | $1,150 | 25.5% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 19 | 139 | $2,780 | $750.56 | 27.0% |
About Dr. Stanley Bunas, MD
Dr. Stanley Bunas, MD is a Specialist healthcare provider based in Bellevue, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1093862120.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stanley Bunas, MD has received a total of $1,844 in payments from pharmaceutical and medical device companies, with $53.72 received in 2022. These payments were reported across 81 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,844).
As a Medicare-enrolled provider, Bunas has provided services to 641 Medicare beneficiaries, totaling 1,200 services with total Medicare billing of $52,483. Data is available for 3 years (2020–2022), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Bellevue, WA
- Active Since 01/04/2007
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1093862120
Products in Payments
- DORYX (Drug) $227.62
- SKYRIZI (Biological) $157.83
- COSENTYX (Biological) $145.05
- Otezla (Drug) $143.94
- DUPIXENT DUPILUMAB INJECTION (Biological) $142.69
- ACZONE (Drug) $118.12
- ENSTILAR (Drug) $110.07
- Humira (Biological) $95.32
- EPIDUO FORTE (Drug) $88.35
- EUCRISA (Drug) $54.54
- STELARA (Biological) $45.09
- DERMATITIS - DISEASE (Drug) $43.68
- DUPIXENT (Biological) $37.07
- ELIDEL (Drug) $25.87
- Cordran (Drug) $25.00
- KERYDIN (Drug) $23.98
- Ameluz (Drug) $22.73
- Skyrizi (Biological) $22.35
- Acticlate (Drug) $20.75
- DUPIXENT (Drug) $17.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Bellevue
Dr. Kathleen Gibson, Md, MD
Specialist — Payments: $831,565
Specialist $831,565
Dr. Brian Ferris, Md, MD
Specialist — Payments: $289,273
Specialist $289,273
Dr. Sam Naficy, M.d., P.s, M.D., P.S
Specialist — Payments: $18,827
Specialist $18,827
Dr. Kevin Johnson, M.d, M.D
Specialist — Payments: $3,326
Specialist $3,326
Mitchell Nudelman, M.d, M.D
Specialist — Payments: $3,050
Specialist $3,050
Elisabeth Anton, M. D, M. D
Specialist — Payments: $1,758
Specialist $1,758